Prologue Medicines Is A Biotechnology Company Founded In 2021 By Flagship Pioneeringthe Company Focuses On Developing Transformative Medicines By Utilizing The Unique Properties Of Viral Proteinsprologue Aims To Expand The Functional Boundaries Of Proteins Beyond The Human Genome Through Systematic Discovery And Evaluation Of Viral Proteins For Therapeutic Applications The Company S Core Innovation Is Its Delvea C Platformwhich Integrates Machine Learning And Computational Biology To Identify Viral Proteins That Can Precisely Regulate Human Physiologyprologue S Primary Service Is Drug Discovery And Developmenttargeting The Pharmaceutical And Healthcare Sectorstheir Approach Is Designed To Create Programmable Medicines That Can Be Tailored To Treat Various Diseases By Leveraging The Functions Of Viral Proteins Prologue Medicines Is Supported By Flagship Pioneeringwhich Provides Capitalexpertiseand A Network To Enhance The Development Of Its Innovative Medicinesthe Company Is Positioned Within A Robust Ecosystem Of Biotech Innovationaiming To Deliver Novel Therapeutic Solutions For A Wide Range Of Diseases
No conferences found for this company.
| Company Name | Prologue Research International Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
